Annual SG&A
$9.74 M
-$3.95 M-28.82%
31 December 2023
Summary:
Imunon annual selling, general & administrative expenses is currently $9.74 million, with the most recent change of -$3.95 million (-28.82%) on 31 December 2023. During the last 3 years, it has risen by +$2.10 million (+27.50%). IMNN annual SG&A is now -28.82% below its all-time high of $13.69 million, reached on 31 December 2022.IMNN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.67 M
-$525.40 K-23.95%
30 September 2024
Summary:
Imunon quarterly selling, general & administrative expenses is currently $1.67 million, with the most recent change of -$525.40 thousand (-23.95%) on 30 September 2024. Over the past year, it has dropped by -$255.10 thousand (-13.26%). IMNN quarterly SG&A is now -58.79% below its all-time high of $4.05 million, reached on 31 December 2022.IMNN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.58 B
-$19.45 M-1.24%
30 September 2024
Summary:
Imunon TTM selling, general & administrative expenses is currently -$1.58 billion, with the most recent change of -$19.45 million (-1.24%) on 30 September 2024. Over the past year, it has dropped by -$1.59 billion (-14005.46%). IMNN TTM SG&A is now -7123.48% below its all-time high of $13.88 million, reached on 31 March 2023.IMNN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -28.8% | -13.3% | -10000.0% |
3 y3 years | +27.5% | -38.6% | -10000.0% |
5 y5 years | +0.5% | -9.3% | -10000.0% |
IMNN Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -28.8% | +27.5% | -58.8% | at low | -23.5% | at low |
5 y | 5 years | -28.8% | +27.5% | -58.8% | at low | -41.4% | at low |
alltime | all time | -28.8% | +627.9% | -58.8% | +880.8% | -7123.5% | at low |
Imunon Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.67 M(-24.0%) | $7.99 M(-3.1%) |
June 2024 | - | $2.19 M(+27.7%) | $8.25 M(-1.7%) |
Mar 2024 | - | $1.72 M(-28.9%) | $8.40 M(-13.8%) |
Dec 2023 | $9.74 M(-28.8%) | $2.41 M(+25.5%) | $9.74 M(-14.4%) |
Sept 2023 | - | $1.92 M(-17.8%) | $11.38 M(-14.7%) |
June 2023 | - | $2.34 M(-23.6%) | $13.34 M(-3.9%) |
Mar 2023 | - | $3.06 M(-24.3%) | $13.88 M(+1.4%) |
Dec 2022 | $13.69 M(+25.7%) | $4.05 M(+4.1%) | $13.69 M(+11.6%) |
Sept 2022 | - | $3.89 M(+35.2%) | $12.27 M(+10.6%) |
June 2022 | - | $2.88 M(+0.2%) | $11.10 M(+2.5%) |
Mar 2022 | - | $2.87 M(+9.2%) | $10.82 M(-0.6%) |
Dec 2021 | $10.89 M(+42.5%) | - | - |
Dec 2021 | - | $2.63 M(-3.3%) | $10.89 M(+5.0%) |
Sept 2021 | - | $2.72 M(+4.4%) | $10.37 M(+9.8%) |
June 2021 | - | $2.60 M(-11.4%) | $9.44 M(+8.0%) |
Mar 2021 | - | $2.94 M(+39.3%) | $8.74 M(+14.4%) |
Dec 2020 | $7.64 M(-4.5%) | $2.11 M(+17.6%) | $7.64 M(+4.1%) |
Sept 2020 | - | $1.79 M(-5.7%) | $7.34 M(-0.6%) |
June 2020 | - | $1.90 M(+3.4%) | $7.39 M(-3.1%) |
Mar 2020 | - | $1.84 M(+1.7%) | $7.62 M(-4.7%) |
Dec 2019 | $8.00 M(-17.5%) | $1.81 M(-1.7%) | $8.00 M(-8.3%) |
Sept 2019 | - | $1.84 M(-14.0%) | $8.72 M(-1.4%) |
June 2019 | - | $2.14 M(-3.7%) | $8.85 M(-13.7%) |
Mar 2019 | - | $2.22 M(-12.4%) | $10.25 M(+5.7%) |
Dec 2018 | $9.70 M(+64.7%) | $2.53 M(+29.2%) | $9.70 M(+10.7%) |
Sept 2018 | - | $1.96 M(-44.7%) | $8.77 M(+9.8%) |
June 2018 | - | $3.54 M(+112.8%) | $7.98 M(+31.1%) |
Mar 2018 | - | $1.67 M(+4.2%) | $6.09 M(+3.3%) |
Dec 2017 | $5.89 M(-9.8%) | $1.60 M(+36.1%) | $5.89 M(-0.7%) |
Sept 2017 | - | $1.17 M(-28.8%) | $5.93 M(-5.2%) |
June 2017 | - | $1.65 M(+12.3%) | $6.25 M(+2.0%) |
Mar 2017 | - | $1.47 M(-10.4%) | $6.13 M(-6.0%) |
Dec 2016 | $6.53 M(-2.4%) | $1.64 M(+9.5%) | $6.53 M(+4.3%) |
Sept 2016 | - | $1.50 M(-2.1%) | $6.26 M(+0.2%) |
June 2016 | - | $1.53 M(-17.9%) | $6.25 M(-4.2%) |
Mar 2016 | - | $1.86 M(+36.0%) | $6.52 M(-2.5%) |
Dec 2015 | $6.69 M(-24.5%) | $1.37 M(-7.7%) | $6.69 M(-9.6%) |
Sept 2015 | - | $1.48 M(-17.7%) | $7.39 M(-7.0%) |
June 2015 | - | $1.80 M(-11.3%) | $7.96 M(-6.0%) |
Mar 2015 | - | $2.03 M(-2.2%) | $8.46 M(-4.5%) |
Dec 2014 | $8.86 M(+35.3%) | $2.08 M(+1.6%) | $8.86 M(+6.7%) |
Sept 2014 | - | $2.04 M(-11.3%) | $8.30 M(+8.6%) |
June 2014 | - | $2.31 M(-5.3%) | $7.65 M(+4.9%) |
Mar 2014 | - | $2.43 M(+60.3%) | $7.29 M(+11.4%) |
Dec 2013 | $6.55 M(+2.7%) | $1.52 M(+9.3%) | $6.55 M(-3.9%) |
Sept 2013 | - | $1.39 M(-28.8%) | $6.82 M(-0.4%) |
June 2013 | - | $1.95 M(+15.5%) | $6.85 M(+5.5%) |
Mar 2013 | - | $1.69 M(-5.5%) | $6.49 M(+1.9%) |
Dec 2012 | $6.37 M(+23.6%) | $1.79 M(+25.8%) | $6.37 M(+9.2%) |
Sept 2012 | - | $1.42 M(-11.0%) | $5.83 M(+0.2%) |
June 2012 | - | $1.60 M(+1.6%) | $5.82 M(+5.7%) |
Mar 2012 | - | $1.57 M(+25.8%) | $5.51 M(+6.9%) |
Dec 2011 | $5.15 M | $1.25 M(-11.4%) | $5.15 M(-2.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2011 | - | $1.41 M(+9.9%) | $5.28 M(+3.7%) |
June 2011 | - | $1.28 M(+5.5%) | $5.10 M(+5.3%) |
Mar 2011 | - | $1.22 M(-11.8%) | $4.84 M(-1.7%) |
Dec 2010 | $4.92 M(+48.0%) | $1.38 M(+13.0%) | $4.92 M(+13.0%) |
Sept 2010 | - | $1.22 M(+19.0%) | $4.36 M(-0.1%) |
June 2010 | - | $1.03 M(-21.1%) | $4.36 M(+10.7%) |
Mar 2010 | - | $1.30 M(+59.9%) | $3.94 M(+18.4%) |
Dec 2009 | $3.33 M(+62.8%) | $812.30 K(-33.6%) | $3.33 M(+12.0%) |
Sept 2009 | - | $1.22 M(+103.1%) | $2.97 M(+31.6%) |
June 2009 | - | $602.40 K(-12.5%) | $2.26 M(+1.0%) |
Mar 2009 | - | $688.20 K(+50.6%) | $2.24 M(-17.9%) |
Dec 2008 | $2.04 M(-61.8%) | $456.90 K(-10.4%) | $2.72 M(-2.6%) |
Sept 2008 | - | $509.80 K(-12.2%) | $2.80 M(-32.6%) |
June 2008 | - | $580.90 K(-50.6%) | $4.15 M(-20.8%) |
Mar 2008 | - | $1.18 M(+122.6%) | $5.24 M(-2.2%) |
Dec 2007 | $5.35 M(+43.8%) | $528.40 K(-71.6%) | $5.35 M(-0.7%) |
Sept 2007 | - | $1.86 M(+11.3%) | $5.39 M(+21.8%) |
June 2007 | - | $1.67 M(+29.1%) | $4.43 M(+14.3%) |
Mar 2007 | - | $1.29 M(+128.0%) | $3.87 M(+4.5%) |
Dec 2006 | $3.72 M(+9.3%) | $567.70 K(-36.5%) | $3.71 M(-4.9%) |
Sept 2006 | - | $893.60 K(-20.1%) | $3.90 M(+2.2%) |
June 2006 | - | $1.12 M(-0.9%) | $3.81 M(+1.2%) |
Mar 2006 | - | $1.13 M(+48.9%) | $3.77 M(+10.6%) |
Dec 2005 | $3.41 M(-1.9%) | $757.20 K(-6.5%) | $3.41 M(-2.6%) |
Sept 2005 | - | $810.20 K(-24.4%) | $3.49 M(+5.2%) |
June 2005 | - | $1.07 M(+39.9%) | $3.32 M(+24.9%) |
Mar 2005 | - | $766.30 K(-9.5%) | $2.66 M(-23.4%) |
Dec 2004 | $3.47 M(-32.3%) | $846.60 K(+32.6%) | $3.47 M(-0.3%) |
Sept 2004 | - | $638.70 K(+56.4%) | $3.48 M(-31.2%) |
June 2004 | - | $408.40 K(-74.1%) | $5.06 M(-9.3%) |
Mar 2004 | - | $1.58 M(+84.0%) | $5.58 M(+8.5%) |
Dec 2003 | - | $857.00 K(-61.4%) | $5.14 M(+0.3%) |
Sept 2003 | $5.13 M(+6.1%) | $2.22 M(+139.9%) | $5.13 M(+21.7%) |
June 2003 | - | $925.30 K(-18.9%) | $4.21 M(-1.5%) |
Mar 2003 | - | $1.14 M(+35.8%) | $4.27 M(-16.7%) |
Dec 2002 | - | $840.00 K(-35.7%) | $5.13 M(+6.2%) |
Sept 2002 | $4.83 M(+50.5%) | $1.31 M(+32.3%) | $4.83 M(+30.7%) |
June 2002 | - | $987.30 K(-50.6%) | $3.70 M(-3.7%) |
Mar 2002 | - | $2.00 M(+269.3%) | $3.84 M(+36.0%) |
Dec 2001 | - | $541.20 K(+218.2%) | $2.82 M(-12.1%) |
Sept 2001 | $3.21 M(+20.7%) | $170.10 K(-84.9%) | $3.21 M(-28.4%) |
June 2001 | - | $1.13 M(+14.7%) | $4.49 M(+17.5%) |
Mar 2001 | - | $982.80 K(+5.6%) | $3.82 M(+6.6%) |
Dec 2000 | - | $930.60 K(-35.6%) | $3.58 M(+13.7%) |
Sept 2000 | $2.66 M(+90.1%) | $1.45 M(+214.1%) | $3.15 M(+39.9%) |
June 2000 | - | $460.20 K(-38.3%) | $2.25 M(+12.6%) |
Mar 2000 | - | $746.40 K(+49.3%) | $2.00 M(+59.5%) |
Dec 1999 | - | $500.00 K(-8.5%) | $1.25 M(+66.3%) |
Sept 1999 | $1.40 M(-44.4%) | $546.50 K(+163.8%) | $753.70 K(+263.8%) |
June 1999 | - | $207.20 K | $207.20 K |
Sept 1998 | $2.52 M(+10.2%) | - | - |
Sept 1997 | $2.28 M(+70.6%) | - | - |
Sept 1996 | $1.34 M | - | - |
FAQ
- What is Imunon annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Imunon?
- What is Imunon annual SG&A year-on-year change?
- What is Imunon quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Imunon?
- What is Imunon quarterly SG&A year-on-year change?
- What is Imunon TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Imunon?
- What is Imunon TTM SG&A year-on-year change?
What is Imunon annual selling, general & administrative expenses?
The current annual SG&A of IMNN is $9.74 M
What is the all time high annual SG&A for Imunon?
Imunon all-time high annual selling, general & administrative expenses is $13.69 M
What is Imunon annual SG&A year-on-year change?
Over the past year, IMNN annual selling, general & administrative expenses has changed by -$3.95 M (-28.82%)
What is Imunon quarterly selling, general & administrative expenses?
The current quarterly SG&A of IMNN is $1.67 M
What is the all time high quarterly SG&A for Imunon?
Imunon all-time high quarterly selling, general & administrative expenses is $4.05 M
What is Imunon quarterly SG&A year-on-year change?
Over the past year, IMNN quarterly selling, general & administrative expenses has changed by -$255.10 K (-13.26%)
What is Imunon TTM selling, general & administrative expenses?
The current TTM SG&A of IMNN is -$1.58 B
What is the all time high TTM SG&A for Imunon?
Imunon all-time high TTM selling, general & administrative expenses is $13.88 M
What is Imunon TTM SG&A year-on-year change?
Over the past year, IMNN TTM selling, general & administrative expenses has changed by -$1.59 B (-14005.46%)